Related Experiment Videos

The impact of obesity on laparoscopic appendectomy: Results from the ACS National Surgical Quality Improvement

Maria Michailidou1, Maria G Sacco Casamassima1, Seth D Goldstein1

  • 1Center for Pediatric Surgical Clinical Trials and Outcomes Research, Division of Pediatric, Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Insights

Childhood obesity does not increase postoperative complications in pediatric laparoscopic appendectomy. Obese children experienced longer operative times but similar complication rates compared to nonobese peers.

Area of Science:

  • Pediatric Surgery
  • Obesity Research
  • Surgical Outcomes

Background:

  • Childhood obesity is a significant public health concern.
  • The impact of elevated body mass index (BMI) on pediatric laparoscopic surgery outcomes is not well understood.
  • Laparoidoscopic appendectomy serves as a model to investigate obesity's effects in pediatric surgery.

Purpose of the Study:

  • To evaluate the association between obesity and perioperative/postoperative complications in children undergoing laparoscopic surgery.
  • To analyze surgical outcomes in obese versus nonobese children using laparoscopic appendectomy as a case study.

Main Methods:

  • Utilized data from the 2012 Pediatric National Surgical Quality Improvement Program (NSQIP).
  • Identified pediatric patients (2-18 years) with acute appendicitis undergoing laparoscopic appendectomy.
  • Defined obesity as BMI ≥95th percentile for age and gender; compared outcomes between obese and nonobese groups using multivariate regression.

Main Results:

  • Included 2812 children; 22% were classified as obese.
  • Obese children had significantly longer operative times.
  • No statistically significant increase in overall or wound complications was observed in obese children after controlling for confounders.

Conclusions:

  • Obesity is not an independent risk factor for postoperative complications after pediatric laparoscopic appendectomy.
  • While operative times are longer, obesity does not elevate the risk of 30-day postoperative complications in this cohort.
Abstract

Related Concept Videos

Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
797
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
1.1K
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
3.7K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
394
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
343